Nexia Biotechnologies Inc Company Profile
Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and BioSteelR.On March 7, 2005, Nexia's, shareholders approved the sale of substantially all its operations and assets related to ProtexiaR to PharmAthene (www.pharmathene.com), a privately held biotechnology company focused on the development of biodefense therapeutics, based in Annapolis, Maryland, USA.
P.O. BOX 187Branch Jean-Talon
Adaptive Biotechnologies said it secured $94 million in private equity funding and used the money to acquire Sequenta, an imm -More-
PORT HUENEME, CA--(Marketwired - October 23, 2014) - Highlighted Links Stellar Biotechnologies Website
PORT HUENEME, CA -- (Marketwired) -- 11/13/14 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limp...
Ophthalmic drug developer Avalanche Biotechnologies Inc. netted $94.9mm in its initial public offering of 6mm common shares at $17 each. The firm had originally planned to sell 5.4mm shares between $1...
Ophthalmic drug developer Avalanche Biotechnologies Inc. netted $109.1mm in its initial public offering of 6.9mm common shares (including the overallotment) at $17 each. The firm had originally planne...
Lion Biotechnologies has submitted an application to the FDA for approval to initiate a midstage trial of its autologous T ce -More-
LOS ANGELES, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCBB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes ...
John Sandles, Business Analyst for Fujifilm Diosynth Biotechnologies, provided commentary on the evolving role of contract services in biologics drug development and manufacturing.
Drugs and Medications
Abstract The absence of comprehensive federal oversight of human biotechnologies in the United States continues to stimulate academic discourse on the relative merits of European-style regulatory agen...
Quick and facile transient RNA interference (RNAi) is one of the most valuable plant biotechnologies for analysing plant gene functions. To establish a novel double-strand RNA (dsRNA) delivery system ...
The aim of connectomics analysis is to understand whole-brain neural connections. This is accomplished using new biotechnologies. Here, we provide an overview of the recent progress in connectomics an...
The performance of a fungal perlite-based biofilter coupled to a post-treatment photoreactor was evaluated over 234 days in terms of n-hexane removal, emission and deactivation of fungal spores. The b...
Nexia Biotechnologies is one of the world's largest producers of authentic recombinant spider silk, and a leading North American animal transgenic company. Nexia manufactures biomaterials and therapeu...
Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and ...
Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...
Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides
More Information about "Nexia Biotechnologies Inc" on BioPortfolio
We have published hundreds of Nexia Biotechnologies Inc news stories on BioPortfolio along with dozens of Nexia Biotechnologies Inc Clinical Trials and PubMed Articles about Nexia Biotechnologies Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nexia Biotechnologies Inc Companies in our database. You can also find out about relevant Nexia Biotechnologies Inc Drugs and Medications on this site too.